GL1X · GenesisL1 explorer

MolNFT v1 · #175215 · protein

SARS cov-2 plpro in complex with GRL0617

7CJM · Non-structural protein 3: “SARS cov-2 plpro in complex with GRL0617”. X-ray diffraction, 2 ligands (TTT, ZN), 2 pockets (best druggability 0.48). MolNFT v1 #175215 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
7CJM
Type
protein
Length
316 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Non-structural protein 3
EC
3.4.19.121, 3.4.22.-
UniProt
P0DTD1
Ligands
TTT, ZN
Pockets
2 · best druggability 0.48

Structure

x-ray diffraction · 1 distinct chain · 25% helix, 34% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
BNon-structural protein 3 (EC 3.4.19.121, 3.4.22.-)protein31625% helix, 34% strandP0DTD1

Ligands and binding sites

  • TTT · 5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide · ligand · chains B
  • ZN · Zinc ion · metal · 3 copies · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11190.480.7924TTT
2720.370.7720empty

Compared structures

  • 7CJM · SARS CoV-2 PLpro in complex with GRL0617 · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.